CR
Insider selling
Chandler Robinson sold $2.6M of MNPR stock
Chandler Robinson, Chief Executive Officer of Monopar Therapeutics (MNPR), sold 29,056 shares of MNPR stock worth $2.6M, per an SEC Form 4 filed Sep 29, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 24, 2026, 5 days before it was made public.
MNPR has moved -19.1% since the trade date, from $88.84 to $71.91 (Oct 29, 2026 close).
- Traded
- Sep 24, 2026
- Disclosed
- Sep 29, 2026
- Filing delay
- 5 days
- Price since
- -19.1%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More MNPR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.